Research programme: G protein-coupled receptor modulators - Domain Therapeutics/TakedaAlternative Names: GPCR modulators drug discovery - Domain/Takeda
Latest Information Update: 20 Nov 2009
At a glance
- Originator Faust Pharmaceuticals; Takeda
- Developer Domain Therapeutics; Takeda
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Unspecified
Most Recent Events
- 09 Nov 2009 Early research is ongoing